Formononetin Inhibits the Development of NSCLC by Targeting HK1 to Reduce Glycolysis Levels

Despite being widely used in the treatment of various diseases, stem cells still need further study due to their many advantages and disadvantages. The possibility of attaching these cells to damaged organs has encouraged many researchers to understand their use. Stem cells are highly divisible cells that can differentiate into different types of other cells, and some, such as nerve cells, may lose the ability to divide., Jscholar is an open access publisher of peer reviewed journals and research articles, which are free to access, share and distribute for the advancement of scholarly communication.

Authors

Publication Details

Journal
Journal of Cancer Research and Therapeutic Oncology
Published
2024-12-10
DOI
https://doi.org/10.17303/jcrto.2024.12.202
Primary Topic
Cancer, Hypoxia, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Formononetin Inhibits the Development of NSCLC by Targeting HK1 to Reduce Glycolysis Levels

Zhiqiong Tan
1 links
Journal of Cancer Research and Therapeutic Oncology
Cancer, Hypoxia, and Metabolism
article

Formononetin Inhibits the Development of NSCLC by Targeting HK1 to Reduce Glycolysis Levels

Zhiqiong Tan
article en

Abstract

Despite being widely used in the treatment of various diseases, stem cells still need further study due to their many advantages and disadvantages. The possibility of attaching these cells to damaged organs has encouraged many researchers to understand their use. Stem cells are highly divisible cells that can differentiate into different types of other cells, and some, such as nerve cells, may lose the ability to divide., Jscholar is an open access publisher of peer reviewed journals and research articles, which are free to access, share and distribute for the advancement of scholarly communication.

Journal of Cancer Research and Therapeutic OncologyVol. 12(2)
Zero hunger
Openalex Percentile: Top 65%
Cancer, Hypoxia, and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Formononetin Inhibits the Development of NSCLC by Targeting HK1 to Reduce Glycolysis Levels — Zhiqiong Tan · Journal of Cancer Research and Therapeutic Oncology (2024) | TGRS Research Map | TGRS